Guidelines for superficial venous thrombosis - PMC
Superficial thrombophlebitis, or superficial venous thrombosis (SVT), is characterized by formation of thrombi inside superficial veins, with involvement or occlusion of the lumen and inflammatory …
Primary (spontaneous) upper extremity deep vein thrombosis
Mar 12, 2024 · The epidemiology, risk factors, pathophysiology, clinical features, diagnosis, and treatment of primary (spontaneous) upper extremity venous thrombosis will be reviewed here.
Basilic vein thrombosis: Symptoms, causes, and treatment
Feb 9, 2024 · This article looks at the symptoms, causes, diagnosis, and treatment for basilic vein thrombosis. It also looks at possible complications, how to help prevent the condition, and its outlook.
Superficial Thrombophlebitis: Symptoms & Causes - Cleveland Clinic
Aug 5, 2022 · Superficial thrombophlebitis, or superficial vein thrombosis, is a blood clot that occurs in veins under the skin (superficial veins). The condition typically happens in the arms or legs and …
What is the recommended treatment for basilic vein thrombosis?
Jul 30, 2025 · For basilic vein thrombosis, initial treatment with low molecular weight heparin (LMWH) followed by at least 3 months of anticoagulation therapy is recommend...
Upper limb: thrombosis of brachial, ulnar, radial, cephalic and basilic veins are managed as SVT. Generally, symptomatic management eg NSAIDS. Repeat scan at 1 week if no improvement or …
How I treat superficial venous thrombosis | Blood | American Society …
Jan 6, 2011 · Thrombosis of superficial veins has long been regarded as a benign disorder.
Basilic Vein Thrombosis: Signs and Treatments - Medicover Hospitals
Jan 8, 2025 · Learn about basilic vein thrombosis symptoms, causes, treatment, and more. Discover how to manage this condition effectively.
Catheter-related upper extremity venous thrombosis in adults
As these devices are often placed in patients who are hypercoagulable, venous thrombosis remains an important adverse outcome of catheter use. The majority (70 to 80 percent) of thrombotic events …
Dec 2, 2019 · anticoagulation for UEDVT in the axillary. 12 ACCP: suggests duration of 3 months. Pulmonary embolism (PE) 2016 ACCP: recommends DOAC over VKA for PE; extend.